ArticleOncogene2024
Targeting DDX11 promotes PARP inhibitor sensitivity in hepatocellular carcinoma by attenuating BRCA2-RAD51 mediated homologous recombination.
Kun Cao et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it